Please enable JavaScript to continue using this application.

Compare $LITS vs $TIL | Chartloom

Compare

$LITS vs $TIL

Lite Strategy Inc · Instil Bio Inc

LITS

Lite Strategy Inc

TIL

Instil Bio Inc

Compare $LITS vs $TIL

Comparing Lite Strategy Inc and Instil Bio Inc

LITSLite Strategy Inc

TILInstil Bio Inc

LITSLite Strategy Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.5%

52W performance

-49.2%

FCF yield

-21.1%

TILInstil Bio Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.2%

52W performance

-67.2%

FCF yield

-73.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LITS

TIL

Detailed metrics comparison

LITS

Lite Strategy Inc

TIL

Instil Bio Inc

Market Cap

LITS$43M

TIL$46M

Enterprise Value

LITS$38M

TIL$125M

Price

LITS$1.27

TIL$6.74

P/E Ratio

LITSN/A

TILN/A

P/S Ratio

LITS0.40x

TIL0.00x

EV/Sales

LITS0.00x

TIL0.00x

EV/EBITDA

LITS0.00x

TIL0.00x

P/B Ratio

LITS1.01x

TIL0.46x

P/FCF Ratio

LITSN/A

TILN/A

EV/FCF

LITS-4.11x

TIL-3.73x

PEG Ratio

LITSN/A

TILN/A

Forward P/E (NTM)

LITSN/A

TILN/A

Forward P/S (NTM)

LITSN/A

TILN/A

Revenue (TTM)

LITS$0

TIL$0

Revenue Growth (YoY)

LITSN/A

TILN/A

Forward Rev Growth

LITS0.0%

TIL0.0%

Gross Margin (TTM)

LITS100.0%

TIL0.0%

Operating Margin (TTM)

LITS34.9%

TIL0.0%

EBITDA Margin (TTM)

LITS0.0%

TIL0.0%

Net Margin (TTM)

LITS39.0%

TIL0.0%

FCF Margin (TTM)

LITSN/A

TILN/A

Net Income (TTM)

LITS$-34M

TIL$-30M

FCF (TTM)

LITS$-9M

TIL$-34M

EPS (TTM)

LITS$0.00

TIL-$4.46

ROE (TTM)

LITS-6886.0%

TIL-2678.0%

ROA (TTM)

LITS-6748.0%

TIL-1489.0%

ROIC (TTM)

LITS-6886.0%

TIL-1529.0%

Cash

LITS$6M

TIL$6M

Debt

LITS$0

TIL$85M

Net Cash/Debt

LITS$6M

TIL$-80M

Current Ratio (TTM)

LITS5.74x

TIL21.67x

Quick Ratio (TTM)

LITS5.34x

TIL21.19x

Debt/Equity (TTM)

LITS0.00x

TIL0.79x

Debt/Assets (TTM)

LITS0.0%

TIL0.0%

Interest Coverage (TTM)

LITSN/A

TILN/A

Net Debt/EBITDA (TTM)

LITS0.00x

TIL0.00x

Beta

LITS0.06

TIL1.90

52W Performance

LITS-49.2%

TIL-67.2%

YTD Performance

LITS-17.5%

TIL-40.2%

% from 52W High

LITS-57.2%

TIL-69.3%

% from 52W Low

LITS84.4%

TIL18.9%

Asset Turnover (TTM)

LITS0.84x

TIL0.00x

FCF Yield (TTM)

LITS-21.1%

TIL-73.6%

Earnings Yield (TTM)

LITS-79.7%

TIL-66.3%

Dividend Yield (TTM)

LITSN/A

TILN/A

Rule of 40

LITS0.0

TIL0.0

EV/GP/RG

LITSN/A

TILN/A

Ticker research

View LITS research View TIL research

Metric	LITS Lite Strategy Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$43M	$46M
Enterprise Value	$38M	$125M
Price	$1.27	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	0.40x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.01x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.11x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	34.9%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	39.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-34M	$-30M
FCF (TTM)	$-9M	$-34M
EPS (TTM)	$0.00	-$4.46
ROE (TTM)	-6886.0%	-2678.0%
ROA (TTM)	-6748.0%	-1489.0%
ROIC (TTM)	-6886.0%	-1529.0%
Financial Health
Cash	$6M	$6M
Debt	$0	$85M
Net Cash/Debt	$6M	$-80M
Current Ratio (TTM)	5.74x	21.67x
Quick Ratio (TTM)	5.34x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.90
52W Performance	-49.2%	-67.2%
YTD Performance	-17.5%	-40.2%
% from 52W High	-57.2%	-69.3%
% from 52W Low	84.4%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.84x	0.00x
FCF Yield (TTM)	-21.1%	-73.6%
Earnings Yield (TTM)	-79.7%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LITS research	View TIL research

Valuation

P/S Ratio

TIL

0.00x

LITS

0.40x

EV/FCF

LITS

-4.11x

TIL

-3.73x

Growth & revenue

Forward Revenue Growth

LITS

0.0%

TIL

0.0%

Profitability & performance

Gross Margin

LITS

100.0%

TIL

0.0%

ROE

TIL

-2678.0%

LITS

-6886.0%

FCF Yield %

LITS

-21.1%

TIL

-73.6%

52-Week Performance

LITS

-49.2%

TIL

-67.2%

Detailed metrics comparison

LITS

Lite Strategy Inc

TIL

Instil Bio Inc

Market Cap

LITS$43M

TIL$46M

Enterprise Value

LITS$38M

TIL$125M

Price

LITS$1.27

TIL$6.74

P/E Ratio

LITSN/A

TILN/A

P/S Ratio

LITS0.40x

TIL0.00x

EV/Sales

LITS0.00x

TIL0.00x

EV/EBITDA

LITS0.00x

TIL0.00x

P/B Ratio

LITS1.01x

TIL0.46x

P/FCF Ratio

LITSN/A

TILN/A

EV/FCF

LITS-4.11x

TIL-3.73x

PEG Ratio

LITSN/A

TILN/A

Forward P/E (NTM)

LITSN/A

TILN/A

Forward P/S (NTM)

LITSN/A

TILN/A

Revenue (TTM)

LITS$0

TIL$0

Revenue Growth (YoY)

LITSN/A

TILN/A

Forward Rev Growth

LITS0.0%

TIL0.0%

Gross Margin (TTM)

LITS100.0%

TIL0.0%

Operating Margin (TTM)

LITS34.9%

TIL0.0%

EBITDA Margin (TTM)

LITS0.0%

TIL0.0%

Net Margin (TTM)

LITS39.0%

TIL0.0%

FCF Margin (TTM)

LITSN/A

TILN/A

Net Income (TTM)

LITS$-34M

TIL$-30M

FCF (TTM)

LITS$-9M

TIL$-34M

EPS (TTM)

LITS$0.00

TIL-$4.46

ROE (TTM)

LITS-6886.0%

TIL-2678.0%

ROA (TTM)

LITS-6748.0%

TIL-1489.0%

ROIC (TTM)

LITS-6886.0%

TIL-1529.0%

Cash

LITS$6M

TIL$6M

Debt

LITS$0

TIL$85M

Net Cash/Debt

LITS$6M

TIL$-80M

Current Ratio (TTM)

LITS5.74x

TIL21.67x

Quick Ratio (TTM)

LITS5.34x

TIL21.19x

Debt/Equity (TTM)

LITS0.00x

TIL0.79x

Debt/Assets (TTM)

LITS0.0%

TIL0.0%

Interest Coverage (TTM)

LITSN/A

TILN/A

Net Debt/EBITDA (TTM)

LITS0.00x

TIL0.00x

Beta

LITS0.06

TIL1.90

52W Performance

LITS-49.2%

TIL-67.2%

YTD Performance

LITS-17.5%

TIL-40.2%

% from 52W High

LITS-57.2%

TIL-69.3%

% from 52W Low

LITS84.4%

TIL18.9%

Asset Turnover (TTM)

LITS0.84x

TIL0.00x

FCF Yield (TTM)

LITS-21.1%

TIL-73.6%

Earnings Yield (TTM)

LITS-79.7%

TIL-66.3%

Dividend Yield (TTM)

LITSN/A

TILN/A

Rule of 40

LITS0.0

TIL0.0

EV/GP/RG

LITSN/A

TILN/A

Ticker research

View LITS research View TIL research

Metric	LITS Lite Strategy Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$43M	$46M
Enterprise Value	$38M	$125M
Price	$1.27	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	0.40x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.01x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.11x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	34.9%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	39.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-34M	$-30M
FCF (TTM)	$-9M	$-34M
EPS (TTM)	$0.00	-$4.46
ROE (TTM)	-6886.0%	-2678.0%
ROA (TTM)	-6748.0%	-1489.0%
ROIC (TTM)	-6886.0%	-1529.0%
Financial Health
Cash	$6M	$6M
Debt	$0	$85M
Net Cash/Debt	$6M	$-80M
Current Ratio (TTM)	5.74x	21.67x
Quick Ratio (TTM)	5.34x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.90
52W Performance	-49.2%	-67.2%
YTD Performance	-17.5%	-40.2%
% from 52W High	-57.2%	-69.3%
% from 52W Low	84.4%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.84x	0.00x
FCF Yield (TTM)	-21.1%	-73.6%
Earnings Yield (TTM)	-79.7%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LITS research	View TIL research